Duchenne Muscular Dystrophy

Is Sarepta Therapeutics Worthy of Redemption?
Motley Fool
Fri, 04/2/21 - 10:52 am
Sarepta Therapeutics
SRP-9001
Duchenne Muscular Dystrophy
Entrada raises $116M to take DMD therapy into the clinic
Fierce Biotech
Wed, 03/31/21 - 10:44 am
Entrada Therapeutics
Duchenne Muscular Dystrophy
Solid Bio’s long, troubled slog through the clinic yields promising early data. Can it win back trust?
Endpoints
Mon, 03/15/21 - 11:58 pm
Solid Biosciences
gene therapy
Duchenne Muscular Dystrophy
FDA Approves Third Sarepta Treatment For Duchenne Muscular Dystrophy
BioSpace
Sun, 02/28/21 - 10:15 pm
Sarepta Therapeutics
Amondys 45
Duchenne Muscular Dystrophy
FDA
PTC aims again for FDA review of Duchenne drug despite latest miss
BioPharma Dive
Sat, 02/6/21 - 11:10 pm
PTC Therapeutics
Translarna
Duchenne Muscular Dystrophy
FDA
Sarepta's DMD gene therapy fails phase 2 motor function test, sinking stock
Fierce Biotech
Fri, 01/8/21 - 09:30 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
clinical trials
SRP-9001
Pfizer beats Sarepta to the start of first late-stage Duchenne gene therapy trial
BioPharma Dive
Thu, 01/7/21 - 11:36 am
Pfizer
Sarepta Therapeutics
clinical trials
Duchenne Muscular Dystrophy
gene therapy
Sarepta shares first results on next-generation Duchenne drug
BioPharma Dive
Tue, 12/8/20 - 11:13 pm
Sarepta Therapeutics
Duchenne Muscular Dystrophy
SRP-5051
Exondys 51
Could Eli Lilly and Precision BioSciences Make Breakthroughs for DMD?
BioSpace
Fri, 11/20/20 - 11:09 am
Eli Lilly
Precision Biosciences
Duchenne Muscular Dystrophy
Santhera axes half its employees and sees CMO depart after PhIII DMD fail
Endpoints
Mon, 11/2/20 - 10:23 am
Santhera
reorganization
Duchenne Muscular Dystrophy
vamorolone
layoffs
Santhera flunks DMD phase 3, prompting restructuring and withdrawal of approval application
Fierce Biotech
Tue, 10/6/20 - 10:40 am
Santhera Pharmaceuticals
clinical trials
Duchenne Muscular Dystrophy
idebenone
FDA Grants Fast Track Designation to Pfizer's DMD Gene Therapy
BioSpace
Fri, 10/2/20 - 12:41 pm
Pfizer
fast track
FDA
Duchenne Muscular Dystrophy
PF-06939926
FDA Lifts Clinical Hold on Solid Biosciences’ DMD Gene Therapy Trial
BioSpace
Thu, 10/1/20 - 11:08 pm
Solid Biosciences
FDA
clinical trials
gene therapy
Duchenne Muscular Dystrophy
New data bolsters Sarepta gene therapies for two deadly muscle diseases
Biopharma Dive
Mon, 09/28/20 - 10:45 am
Sarepta Therapeutics
gene therapy
Duchenne Muscular Dystrophy
Limb Girdle Muscular Dystrophy
SRP-9001
SRP-9003
Sarepta faces another gene therapy hiccup as Regenxbio sues over Jim Wilson's patent
Endpoints
Thu, 09/17/20 - 10:40 am
Sarepta Therapeutics
gene therapy
Regenxbio
Duchenne Muscular Dystrophy
Sarepta cites 'overburdened' FDA as factor in DMD gene therapy delay
Fierce Biotech
Fri, 09/11/20 - 10:55 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
gene therapy
FDA
Sarepta shares fall on potential regulatory delay for experimental Duchenne drug
Marketwatch
Thu, 09/10/20 - 10:21 am
Sarepta Therapeutics
Duchenne Muscular Dystrophy
SRP-9001
Santhera bags DMD drug in 3-way deal with Idorsia and ReveraGen
Fierce Biotech
Wed, 09/2/20 - 11:04 am
Santhera
vamorolone
Duchenne Muscular Dystrophy
Idorsia
ReveraGen
Sarepta Therapeutics Gets Fast-Track FDA Review For Muscular Dystrophy Drug
Investors Business Daily
Tue, 08/25/20 - 10:00 pm
Sarepta Therapeutics
FDA
fast track
Duchenne Muscular Dystrophy
casimersen
FDA gives speedy approval to another Duchenne drug
BioPharma Dive
Wed, 08/12/20 - 11:58 pm
FDA
NS Pharma
Japan
Duchenne Muscular Dystrophy
Viltepso
viltolarsen

Pages